Sutro Biopharma, Inc. (STRO)

NASDAQ: STRO · Real-Time Price · USD

0.7940

+0.0281 (3.67%)

Jul 18, 2025, 9:42 AM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Site-specific and Novel-format Antibody Drug Conjugates	153.73M	Log In	Log In	Log In	Log In	Upgrade
Site-specific and Novel-format Antibody Drug Conjugates Growth	126.84%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	153.73M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	126.84%	Log In	Log In	Log In	Log In	Upgrade